CLINICAL CHEMISTRY AND LABORATORY MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2020-05-19 12462fd4m67暂无昵称

同问136****9146暂无昵称 2019-09-16 00:00:00 发表:
咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下

136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下

148 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2020-05-17 格格巫婆婆

请问一下这个杂志接受不约稿的综述吗

129 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

169 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-09-16 123a7dccm46暂无昵称

咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下

221 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-09-11 zhanghaixia_2005

您投的是哪方面的wait2020 2018-10-31 00:00:00 发表:
抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。

wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。

161 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-08-31 124aa749m82暂无昵称

接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表::
投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表:
投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……

185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……

178 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-06-18 1215c9fbm69(暂无昵称)

投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……

171 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-01-31 LancetYAO

接受率5%，meta投稿说质量不高，一天被拒

203 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2019-01-25 wait2020

对的134****5408 2018-12-24 00:00:00 发表:
最牛的是clinical chemistry吗？

134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？

223 0

[GetPortalCommentsPageByObjectIdResponse(id=591209, encodeId=35205912092b, content=同问136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=136****9146暂无昵称 2019-09-16 00:00:00 发表: 咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa12483512, createdName=12462fd4m67暂无昵称, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591048, encodeId=61fe5910486b, content=请问一下这个杂志接受不约稿的综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GWWxo8xjPUX9bIricIaKf4sKrds0xIg1LKbZ3z1zZuz6QMiaOia5HkcSeYEK9lZQBAurdbngWFTICuJnEbuD6yXDQ/132, createdBy=2c855322216, createdName=格格巫婆婆, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578852, encodeId=91c75e88528f, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576375, encodeId=d9f75e63751f, content=咨询一下各位前辈:投此刊，通信作者必须是投稿账号投稿才可以吗？能否用其他账号投稿后修改通信作者？第二个问题？投稿时文章必须要和表格，图片分开上传吗？我没找到具体说明，谢谢路过的前辈指点一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8b2426178, createdName=123a7dccm46暂无昵称, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576165, encodeId=0d4f5e616591, content=您投的是哪方面的wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4f14724893, createdName=zhanghaixia_2005, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575632, encodeId=5e8f5e563248, content=接受了吗185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……185YK9M5869(暂无昵称) 2019-06-18 00:00:00 发表: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=185YK9M5869(暂无昵称) 2019-06-18 发表:: 投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7be2505431, createdName=124aa749m82暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572411, encodeId=e63e5e2411eb, content=投稿一个半月，under review 一个月了，还在review，以前reject挺快的，这次不知道啥情况，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/07/b2dedb88115673a5bdc4acd42ef0bcce.jpg, createdBy=b26d2248426, createdName=1215c9fbm69(暂无昵称), createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566368, encodeId=dc4c566368f5, content=接受率5%，meta投稿说质量不高，一天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566091, encodeId=c43e5660910b, content=对的134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, beContent=134****5408 2018-12-24 00:00:00 发表: 最牛的是clinical chemistry吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564857, encodeId=94a656485efe, content=版面费多少？wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1bc1699114, createdName=LancetYAO, createdTime=Tue Dec 25 00:00:00 CST 2018, time=2018-12-25, status=1, ipAttribution=)]

2018-12-25 LancetYAO

版面费多少？wait2020 2018-10-31 00:00:00 发表:
抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。

wait2020 2018-10-31 00:00:00 发表: 抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。

199 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务